|
|
大分割放疗治疗非小细胞肺癌的临床研究进展
|
Abstract:
放射治疗是恶性肿瘤的重要治疗手段之一，常规分割作为最常用的放疗模式，存在治疗总次数多、治疗周期长等缺点。随着放疗设备及技术的进步，大分割放疗已成为乳腺癌、宫颈癌等肿瘤的标准治疗方式。但大分割放疗在非小细胞肺癌中的有效性和安全性还未得到充分证实。本文对大分割放疗在非小细胞肺癌中的应用、疗效及安全性的研究进展进行综述。
Radiotherapy is one of the most important treatment methods for malignant tumors. Conventional segmentation, as the most commonly used radiotherapy mode, has many disadvantages such as the total number of treatments and long treatment cycle. With the development of radiotherapy equipment and technology, large segmentation radiotherapy has become a standard treatment for breast cancer, cervical cancer and other tumors. However, the efficacy and safety of large fractionation radiotherapy in non-small cell lung cancer have not been fully demonstrated. This article reviews the application, efficacy and safety of large fractionation radiotherapy in non-small cell lung cancer.
| [1] | World Health Organization (WHO) (2020) Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country, and by Region, 2000-2019. |
| [2] | Siegel, R.L., Miller, K.D., Wagle, N.S. and Jemal, A. (2023) Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 17-48. https://doi.org/10.3322/caac.21763 |
| [3] | Klepetko, W. (2017) ED10.02 the Role of Surgery in Stage III NSCLC. Journal of Thoracic Oncology, 12, S46-S48. https://doi.org/10.1016/j.jtho.2016.11.042 |
| [4] | 张赛, 程鹏, 杨红杰, 等. 大分割调强放疗治疗局部晚期非小细胞肺癌的临床分析[J]. 中国实用医药, 2021, 16(4): 1-3. |
| [5] | 丁曼华, 徐海亭, 王强, 等. 安罗替尼联合大分割放疗治疗非小细胞肺癌脑转移的临床疗效及不良反应[J]. 徐州医科大学学报, 2022, 42(8): 558-563. |
| [6] | Yin, L., Xue, J., Li, R., Zhou, L., Deng, L., Chen, L., et al. (2020) Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-Pd1 in Mice and Patients with Non-Small Cell Lung Cancer. International Journal of Radiation Oncology Biology Physics, 108, 212-224. https://doi.org/10.1016/j.ijrobp.2020.05.002 |
| [7] | Kim, M., Kim, W., Park, I.H., Kim, H.J., Lee, E., Jung, J., et al. (2015) Radiobiological Mechanisms of Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery. Radiation Oncology Journal, 33, 265-275. https://doi.org/10.3857/roj.2015.33.4.265 |
| [8] | Siegel, R.L., Miller, K.D., Fuchs, H.E. and Jemal, A. (2022) Cancer Statistics, 2022. CA: A Cancer Journal for Clinicians, 72, 7-33. https://doi.org/10.3322/caac.21708 |
| [9] | Videtic, G.M.M., Donington, J., Giuliani, M., Heinzerling, J., Karas, T.Z., Kelsey, C.R., et al. (2017) Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Practical Radiation Oncology, 7, 295-301. https://doi.org/10.1016/j.prro.2017.04.014 |
| [10] | Guckenberger, M., Andratschke, N., Dieckmann, K., Hoogeman, M.S., Hoyer, M., Hurkmans, C., et al. (2017) ESTRO ACROP Consensus Guideline on Implementation and Practice of Stereotactic Body Radiotherapy for Peripherally Located Early Stage Non-Small Cell Lung Cancer. Radiotherapy and Oncology, 124, 11-17. https://doi.org/10.1016/j.radonc.2017.05.012 |
| [11] | 张佳佳, 曹一鹏, 陈思颖, 等. 大分割放疗在局部晚期或晚期非小细胞肺癌中的疗效[J]. 中华放射肿瘤学杂志, 2021, 30(10): 1002-1006. https://doi.org/10.3760/cma.j.cn113030-20200728-00383 |
| [12] | 王芳, 王辛. 根治性前列腺癌低分割放疗的研究进展[J]. 中华放射肿瘤学杂志, 2022, 31(1): 102-107. https://doi.org/10.3760/cma.j.cn113030-20211007-00390 |
| [13] | Qiu, B., Aili, A., Xue, L., Jiang, P. and Wang, J. (2020) Advances in Radiobiology of Stereotactic Ablative Radiotherapy. Frontiers in Oncology, 10, Article 1165. https://doi.org/10.3389/fonc.2020.01165 |
| [14] | Kim, J., Lee, H., Wu, H., Chie, E.K., Kang, H. and Park, J.M. (2017) Development of Patient-Controlled Respiratory Gating System Based on Visual Guidance for Magnetic-Resonance Image-Guided Radiation Therapy. Medical Physics, 44, 4838-4846. https://doi.org/10.1002/mp.12447 |
| [15] | 赵晶晶, 毕楠, 张涛, 等. 局限期小细胞肺癌大分割调强放疗相关不良反应分析[J]. 中华肿瘤杂志, 2023, 45(7): 627-633. https://doi.org/10.3760/cma.j.cn112152-20221031-00733 |
| [16] | Haasbeek, C.J.A., Lagerwaard, F.J., Slotman, B.J. and Senan, S. (2011) Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer. Journal of Thoracic Oncology, 6, 2036-2043. https://doi.org/10.1097/jto.0b013e31822e71d8 |
| [17] | Chun, S.G., Hu, C., Choy, H., Komaki, R.U., Timmerman, R.D., Schild, S.E., et al. (2017) Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial. Journal of Clinical Oncology, 35, 56-62. https://doi.org/10.1200/jco.2016.69.1378 |
| [18] | Takanen, S., Bottero, M., Nisticò, P. and Sanguineti, G. (2022) A Systematic Review on the Impact of Hypofractionated and Stereotactic Radiotherapy on Immune Cell Subpopulations in Cancer Patients. Cancers, 14, Article 5190. https://doi.org/10.3390/cancers14215190 |
| [19] | Wang, F. and Wang, X. (2022) Research Progress on Radical Hypofractionated Radiotherapy for Prostate Cancer. Chinese Journal of Radiation Oncology, 31, 102-107. |
| [20] | Dall’Olio, F.G., Maggio, I., Massucci, M., Mollica, V., Fragomeno, B. and Ardizzoni, A. (2020) ECOG Performance Status ≥ 2 as a Prognostic Factor in Patients with Advanced Non Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors—A Systematic Review and Meta-Analysis of Real World Data. Lung Cancer, 145, 95-104. https://doi.org/10.1016/j.lungcan.2020.04.027 |
| [21] | Park, S.J., Kim, H.T., Han, Y., et al. (2011) Dosimetric Benefit of the Synchrony Respiratory Tracking System for Hypofractionated Intensity-Modulated Radiotherapy: Assessed via Four-Dimensional Dose Calculation. Radiation Oncology Journal, 29, 306-316. |
| [22] | Puri, S., Saltos, A., Perez, B., Le, X. and Gray, J.E. (2020) Locally Advanced, Unresectable Non-Small Cell Lung Cancer. Current Oncology Reports, 22, Article No. 31. https://doi.org/10.1007/s11912-020-0882-3 |
| [23] | Farr, K.P., Khalil, A.A. and Grau, C. (2019) Patient-Reported Lung Symptoms and Quality of Life before and after Radiation Therapy for Non-Small Cell Lung Cancer: Correlation with Radiation Pneumonitis and Functional Imaging. Acta Oncologica, 58, 1523-1527. https://doi.org/10.1080/0284186x.2019.1634835 |
| [24] | Qiu, B., Xiong, M., Luo, Y., Li, Q., Chen, N., Chen, L., et al. (2021) Hypofractionated Intensity Modulated Radiation Therapy with Concurrent Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer: A Phase II Prospective Clinical Trial (GASTO1011). Practical Radiation Oncology, 11, 374-383. https://doi.org/10.1016/j.prro.2021.06.004 |
| [25] | Palma, D.A., Salama, J.K., Lo, S.S., Senan, S., Treasure, T., Govindan, R., et al. (2014) The Oligometastatic State—Separating Truth from Wishful Thinking. Nature Reviews Clinical Oncology, 11, 549-557. https://doi.org/10.1038/nrclinonc.2014.96 |
| [26] | 冯勤付, 郑苗丽, 曾强. 放射性肺炎的诊断和治疗[J]. 中华放射肿瘤学杂志, 2021, 30(1): 7-10. |
| [27] | Guckenberger, M., Andratschke, N., Alheit, H., Holy, R., Moustakis, C., Nestle, U., et al. (2013) Definition of Stereotactic Body Radiotherapy. Strahlentherapie und Onkologie, 190, 26-33.？ https://doi.org/10.1007/s00066-013-0450-y |
| [28] | Gomez, D.R., Tang, C., Zhang, J., Blumenschein, G.R., Hernandez, M., Lee, J.J., et al. (2019) Local Consolidative Therapy vs. Maintenance Therapy or Observation for Patients with Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. Journal of Clinical Oncology, 37, 1558-1565. https://doi.org/10.1200/jco.19.00201 |
| [29] | 翟丽君. 肺癌放疗患者放射性肺炎发生情况及影响因素探讨[J]. 中国现代药物应用, 2020, 14(18): 25-26. |
| [30] | 张永彤, 王春春, 黄芳, 等. 肺癌放射治疗造成急性放射性肺炎的临床治疗研究[J]. 中国全科医学, 2021, 24(S1): 103-105. |
| [31] | Miko Enomoto, T., Johnson, T., Peterson, N., Homer, L., Walts, D. and Johnson, N. (2005) Combination Glutathione and Anthocyanins as an Alternative for Skin Care during External-Beam Radiation. The American Journal of Surgery, 189, 627-631. https://doi.org/10.1016/j.amjsurg.2005.02.001 |
| [32] | Clausen, A.E., Kast, C.E. and Bernkop-Schnürch, A. (2002) The Role of Glutathione in the Permeation Enhancing Effect of Thiolated Polymers. Pharmaceutical Research, 19, 602-608. https://doi.org/10.1023/a:1015345827091 |
| [33] | 闫立辉, 彭晓梅, 杨宇, 等. 复方苦参注射液防治非小细胞肺癌放疗患者放射性肺损伤及骨髓抑制的效果[J]. 检验医学与临床, 2021, 18(19): 2888-2890. |
| [34] | Patibandla, A., Featherstone, C., Maclaren, V., Lumsden, G., Harrow, S., Jones, R., et al. (2020) Hypofractionated Accelerated Concurrent Chemoradiotherapy in Inoperable Stage III Non-Small Cell Lung Cancer: SOCCAR. A Large Single-Centre Experience. Clinical Oncology, 32, e211. https://doi.org/10.1016/j.clon.2020.06.006 |
| [35] | Lan, J., Li, R., Yin, L., Deng, L., Gui, J., Chen, B., et al. (2018) Targeting Myeloid-Derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared with Conventional Fractionated Radiation Therapy. International Journal of Radiation Oncology Biology Physics, 101, 74-87. https://doi.org/10.1016/j.ijrobp.2018.01.071 |
| [36] | Kong, C., Zhu, X., Shi, M., Wang, L., Chen, C., Tao, H., et al. (2020) Survival and Toxicity of Hypofractionated Intensity Modulated Radiation Therapy in 4 Gy Fractions for Unresectable Stage III Non-Small Cell Lung Cancer. International Journal of Radiation Oncology Biology Physics, 107, 710-719. https://doi.org/10.1016/j.ijrobp.2020.03.038 |
| [37] | Iocolano, M., Wild, A.T., Hannum, M., Zhang, Z., Simone, C.B., Gelblum, D., et al. (2019) Hypofractionated vs. Conventional Radiation Therapy for Stage III Non-Small Cell Lung Cancer Treated without Chemotherapy. Acta Oncologica, 59, 164-170. https://doi.org/10.1080/0284186x.2019.1675907 |
| [38] | Goto, M., Sanuki, N., Kasae, M., Terabayashi, R., Nishiwaki, Y., Ogita, Y., et al. (2022) Dynamic Conformal Arc Radiotherapy for Locally Advanced Lung Cancer: A Comparison with Static-Beam Conformal Radiotherapy. Reports of Practical Oncology and Radiotherapy, 27, 897-904. https://doi.org/10.5603/rpor.a2022.0106 |
| [39] | Ettinger, D.S., Wood, D.E., Aisner, D.L., Akerley, W., Bauman, J.R., Bharat, A., et al. (2022) Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 20, 497-530. https://doi.org/10.6004/jnccn.2022.0025 |
| [40] | Liu, X., Dai, J., Xu, X., et al. (2016) Determination of Optimal Treatment Planning Duration for Hypofractionated Radiotherapy with Large Volumes Based on Tumor Cell Kinetics and Potential Doubling Time. Scientific Reports, 6, Article No. 34770. |
